Management of patients with chronic kidney disease: a French medical centre database analysis.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Matthieu Ariza, Steven Martin, Mikaël Dusenne, David Darmon, Matthieu Schuers
{"title":"Management of patients with chronic kidney disease: a French medical centre database analysis.","authors":"Matthieu Ariza, Steven Martin, Mikaël Dusenne, David Darmon, Matthieu Schuers","doi":"10.1093/fampra/cmad004","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective(s): </strong>Chronic kidney disease (CKD) is an insidious disease that requires early nephroprotective measures to delay progression to end-stage kidney disease. The objective of this study was to describe the management of patients with CKD in primary care, including clinical and biological monitoring and prescribed treatments. A retrospective, single-centre study was conducted on adult patients who were treated in the Maison de Neufchâtel (France) between 2012 and 2017 at least once a year. The inclusion criteria were 2 estimated glomerular filtration rate (eGFR) measurements <60 mL/min more than 3 months apart. Two subgroups were constituted according to whether CKD was coded in the electronic medical records (EMRs).</p><p><strong>Results: </strong>A total of 291 (6.7%, CI95% 5.9-7.4) patients with CKD were included. The mean eGFR was 51.0 ± 16.4 mL/min. Hypertension was the most frequent health problem reported (n = 93, 32%). Nephrotective agents were prescribed in 194 (66.7%) patients, non-steroidal anti-inflammatory drugs (NSAIDs) in 22 (8%) patients, and proton-pump inhibitors (PPIs) in 147 (47%) patients. CKD coding in EMRs was associated with dosage of natraemia (n = 34, 100%, P < 0.01), albuminuria (n = 20, 58%, P < 0.01), vitamin D (n = 14, 41%, P < 0.001), and phosphorus (n = 11, 32%, P < 0.001). Eighty-one patients (31.5%) with low eGFR without an entered code for CKD were prescribed an albuminuria dosage. Clinical monitoring could not be analysed due to poor coding.</p><p><strong>Conclusion: </strong>This pilot study reinforces the hypothesis that CKD is underscreened and undermanaged. More systematic coding of medical information in EMRs and further studies on medical centre databases should improve primary care practices.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/fampra/cmad004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective(s): Chronic kidney disease (CKD) is an insidious disease that requires early nephroprotective measures to delay progression to end-stage kidney disease. The objective of this study was to describe the management of patients with CKD in primary care, including clinical and biological monitoring and prescribed treatments. A retrospective, single-centre study was conducted on adult patients who were treated in the Maison de Neufchâtel (France) between 2012 and 2017 at least once a year. The inclusion criteria were 2 estimated glomerular filtration rate (eGFR) measurements <60 mL/min more than 3 months apart. Two subgroups were constituted according to whether CKD was coded in the electronic medical records (EMRs).

Results: A total of 291 (6.7%, CI95% 5.9-7.4) patients with CKD were included. The mean eGFR was 51.0 ± 16.4 mL/min. Hypertension was the most frequent health problem reported (n = 93, 32%). Nephrotective agents were prescribed in 194 (66.7%) patients, non-steroidal anti-inflammatory drugs (NSAIDs) in 22 (8%) patients, and proton-pump inhibitors (PPIs) in 147 (47%) patients. CKD coding in EMRs was associated with dosage of natraemia (n = 34, 100%, P < 0.01), albuminuria (n = 20, 58%, P < 0.01), vitamin D (n = 14, 41%, P < 0.001), and phosphorus (n = 11, 32%, P < 0.001). Eighty-one patients (31.5%) with low eGFR without an entered code for CKD were prescribed an albuminuria dosage. Clinical monitoring could not be analysed due to poor coding.

Conclusion: This pilot study reinforces the hypothesis that CKD is underscreened and undermanaged. More systematic coding of medical information in EMRs and further studies on medical centre databases should improve primary care practices.

慢性肾病患者的管理:法国医疗中心数据库分析。
目的:慢性肾脏病(CKD)是一种隐匿性疾病:慢性肾脏病(CKD)是一种隐匿性疾病,需要尽早采取肾脏保护措施,以延缓发展为终末期肾脏病。本研究旨在描述初级医疗机构对慢性肾脏病患者的管理,包括临床和生物监测以及处方治疗。这项回顾性单中心研究的对象是2012年至2017年间在法国新堡医院接受治疗的成年患者,每年至少接受一次治疗。纳入标准为两次估计肾小球滤过率(eGFR)测量结果:共纳入 291 名(6.7%,CI95% 5.9-7.4)慢性肾脏病患者。平均 eGFR 为 51.0 ± 16.4 mL/min。高血压是最常见的健康问题(n = 93,32%)。194名患者(66.7%)使用了肾脏保护剂,22名患者(8%)使用了非甾体抗炎药(NSAIDs),147名患者(47%)使用了质子泵抑制剂(PPIs)。EMR中的CKD编码与正铁血症(34人,100%,P<0.01)、白蛋白尿(20人,58%,P<0.01)、维生素D(14人,41%,P<0.001)和磷(11人,32%,P<0.001)的剂量有关。81名(31.5%)低 eGFR 但未输入 CKD 代码的患者被处方了白蛋白尿剂量。由于编码不准确,无法对临床监测结果进行分析:这项试点研究加强了 CKD 未得到充分筛查和管理的假设。对 EMR 中的医疗信息进行更系统的编码,并对医疗中心数据库进行进一步研究,应能改善初级保健实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信